Marietta, GA, United States of America

Jennifer R Louten

This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer R Louten. Retrieved from https://idiyas.com/inventor/jennifer-r-louten

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jennifer R. Louten

Introduction

Jennifer R. Louten is an accomplished inventor based in Marietta, GA (US). She has made significant contributions to the field of biomedical research, particularly in the area of treatment for various conditions. Her work focuses on the development of innovative solutions that can improve patient outcomes.

Latest Patents

Jennifer holds a patent for "Biomarkers for TSLP treatment." This invention relates to biomarkers that are responsive to treatment with an anti-Thymic Stromal Lymphopoietin (TSLP) antibody. This advancement has the potential to enhance therapeutic strategies for patients requiring TSLP treatment.

Career Highlights

Jennifer is currently employed at Merck Sharp & Dohme Corp., where she continues to push the boundaries of medical research. Her dedication to innovation has led to her recognition in the field, and she is known for her commitment to improving healthcare solutions.

Collaborations

Throughout her career, Jennifer has collaborated with notable colleagues, including Maribel Beaumont and Jeanine D. Mattson. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Jennifer R. Louten's contributions to the field of biomedical research exemplify the impact of innovation in healthcare. Her work on biomarkers for TSLP treatment showcases her commitment to improving patient care through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…